Choosing an animal model for the study of Huntington's disease
- PMID: 24052178
- DOI: 10.1038/nrn3570
Choosing an animal model for the study of Huntington's disease
Abstract
Since the identification of the causative gene in Huntington's disease (HD), a number of animal models of this disorder have been developed. A frequently asked question is: which of these models most closely recapitulates the human disease? In this Review, we provide an overview of the currently available animal models of HD in the context of the clinical features of the disease. In doing so, we highlight their strengths and limitations for modelling specific symptoms of the disease. This should highlight the animal model that is best suited to address a particular question of interest and, ultimately, to expedite the discovery of treatments that will prevent or slow the progression of HD.
Similar articles
-
Genetic modifiers of Huntington's disease.Mov Disord. 2014 Sep 15;29(11):1359-65. doi: 10.1002/mds.26001. Epub 2014 Aug 25. Mov Disord. 2014. PMID: 25154728 Review.
-
Hypothalamic and neuroendocrine changes in Huntington's disease.Curr Drug Targets. 2010 Oct;11(10):1237-49. doi: 10.2174/1389450111007011237. Curr Drug Targets. 2010. PMID: 20594177 Review.
-
Mind the gap: models in multiple species needed for therapeutic development in Huntington's disease.Mov Disord. 2014 Sep 15;29(11):1397-403. doi: 10.1002/mds.26008. Epub 2014 Aug 22. Mov Disord. 2014. PMID: 25155258 Review.
-
Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.J Comp Neurol. 2003 Oct 6;465(1):11-26. doi: 10.1002/cne.10776. J Comp Neurol. 2003. PMID: 12926013
-
[Huntington's disease: clinical and molecular genetics].Nihon Rinsho. 1999 Apr;57(4):896-9. Nihon Rinsho. 1999. PMID: 10222786 Review. Japanese.
Cited by
-
Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease.Elife. 2018 Sep 4;7:e38744. doi: 10.7554/eLife.38744. Elife. 2018. PMID: 30179155 Free PMC article.
-
Antagonistic pleiotropy in mice carrying a CAG repeat expansion in the range causing Huntington's disease.Sci Rep. 2019 Jan 10;9(1):37. doi: 10.1038/s41598-018-37102-8. Sci Rep. 2019. PMID: 30631090 Free PMC article.
-
A protein quality control pathway regulated by linear ubiquitination.EMBO J. 2019 May 2;38(9):e100730. doi: 10.15252/embj.2018100730. Epub 2019 Mar 18. EMBO J. 2019. PMID: 30886048 Free PMC article.
-
Mechanisms of protein toxicity in neurodegenerative diseases.Cell Mol Life Sci. 2018 Sep;75(17):3159-3180. doi: 10.1007/s00018-018-2854-4. Epub 2018 Jun 12. Cell Mol Life Sci. 2018. PMID: 29947927 Free PMC article. Review.
-
Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease.J Mol Med (Berl). 2020 Mar;98(3):325-334. doi: 10.1007/s00109-020-01885-z. Epub 2020 Feb 8. J Mol Med (Berl). 2020. PMID: 32036391 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical